Compare ENSC & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ENSC | OMH |
|---|---|---|
| Founded | 2003 | 2015 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 3.2M |
| IPO Year | 2017 | 2022 |
| Metric | ENSC | OMH |
|---|---|---|
| Price | $0.43 | $0.11 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 21.4M | ★ 31.8M |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 65.24 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,066,650.00 | N/A |
| Revenue This Year | $55.01 | $28.40 |
| Revenue Next Year | $1,033.97 | $23.07 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.23 | $0.09 |
| 52 Week High | $2.75 | $2.19 |
| Indicator | ENSC | OMH |
|---|---|---|
| Relative Strength Index (RSI) | 65.10 | 38.05 |
| Support Level | $0.27 | N/A |
| Resistance Level | $0.65 | $1.09 |
| Average True Range (ATR) | 0.08 | 0.17 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 27.08 | 1.76 |
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.
Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, Digital Marketing Services, and emerging and other services. The firm operates in two segments, which are Brokerage, emerging and another related service; and Estate management services and other related services in Singapore.